11 research outputs found

    Vaginal Evisceration: An Unexpected Complication of Conization

    Get PDF
    Background. Large loop excision of the transformation zone (LLETZ) is routinely performed for the management of high grade intracervical neoplasia (CIN). Several uncommon complications have been described, including postoperative peritonitis, pseudoaneurysm of uterine artery, and bowel fistula. We report a unique case of postoperative vaginal evisceration and the subsequent management. Case. A 73-years-old woman underwent LLETZ for high grade CIN. On postoperative day 3, she was admitted for small bowel evisceration through the vagina. Surgical management was based on combined laparoscopic and transvaginal approach and consisted in bowel inspection and reinstatement, peritoneal washing, and dehiscence repair. Conclusions. Vaginal evisceration is a rare but potentially serious complication of pelvic surgery. This case report is to make clinicians aware of such complication following LLETZ and its management

    Conséquences fonctionnelles ano-rectales du premier accouchement par voie vaginale, impact des spatules de Thierry (étude prospective à propos de 643 patientes)

    No full text
    Contexte : L'incontinence anale du post-partum est un symptĂŽme mal connu malgrĂ© des taux importants rapportĂ©s par la littĂ©rature. Il est donc intĂ©ressant d'Ă©tudier ce symptĂŽme ainsi que les troubles associĂ©s (incontinence urinaire, douleurs pĂ©rinĂ©ales et troubles sexuels) et d'essayer d'en dĂ©finir les facteurs de risque. Nous avons notamment voulu savoir si les spatules de Thierry Ă©taient un facteur de risque d'incontinence anale. MatĂ©riel et mĂ©thode : Nous avons menĂ© une Ă©tude observationnelle prospective au sein de la maternitĂ© Paule de Viguier (type III, CHU Toulouse) entre dĂ©cembre 2005 et dĂ©cembre 2006. L'Ă©tude a Ă©tĂ© rĂ©alisĂ©e Ă  l'aide d'auto-questionnaires anonymes administrĂ©s Ă  2 jours puis 2 et 6 mois post-partum, aprĂšs avoir relevĂ© les caractĂ©ristiques de l'accouchement. RĂ©sultats : 643 patientes ont Ă©tĂ© prĂ©-incluses (primipares accouchant par voie basse d'un singleton en prĂ©sentation cĂ©phaliques spontanĂ©ment ou par spatules de Thierry). 561 ont signĂ© le formulaire de consentement et notre taux de rĂ©ponse est de 86% Ă  2 mois et 81% Ă  6 mois. La seule diffĂ©rence existant entre les populations accouchant spontanĂ©ment ou par spatules de Thierry est l'Ăąge plus Ă©levĂ© des femmes dans le deuxiĂšme groupe. Le taux d'Ă©pisiotomie est significativement plus Ă©levĂ© dans le groupe spatules (97,5% vs 50,3% p= 5) est de 11% Ă  2 mois et 7,7% Ă  6 mois. Il existe une association statistique entre l'incontinence anale et l'incontinence urinaire, les douleurs pĂ©rinĂ©ales et les troubles sexuels (dĂ©lai de reprise des rapports). L'analyse univariĂ©e (confirmĂ©e par l'analyse multivariĂ©e) montre que les facteurs de risque d'incontinence anale Ă  2 et 6 mois du post-partum sont les dĂ©chirures pĂ©rinĂ©ales sĂ©vĂšres (OR=4,60 [1,14-31,11]), l'Ă©pisiotomie (OR=3,13 [1,31-6,87]), l'Ăąge Ă©levĂ© de la patiente (OR=1,08 [1,008-1,15]). Discussion : Notre Ă©tude confirme les taux et les facteurs de risques classiques d'incontinence anale post-partum. Nous montrons un impact nĂ©gatif important de l'Ă©pisiotomie. En revanche, les spatules de Thierry n'apparaissent pas comme un facteur de risque indĂ©pendant d'incontinence anale tout en ne montrant pas non plus d'effet dĂ©lĂ©tĂšre sur l'Ă©tat nĂ©onatal. C'est donc un instrument moderne et efficace qui doit continuer Ă  ĂȘtre enseignĂ© mais l'Ă©volution des pratiques doit probablement tendre vers une rĂ©duction raisonnĂ©e du taux d'Ă©pisiotomie. Une Ă©tude comparant un usage restrictif et libĂ©ral de l'Ă©pisiotomie en cas d'extraction par spatule ainsi qu'une Ă©tude randomisĂ©e prospective comparant les spatules aux autres instruments d'extraction fƓtale pourraient valider les donnĂ©es de notre Ă©tude.TOULOUSE3-BU SantĂ©-Centrale (315552105) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

    Finally an evidence-based indication for injectable phloroglucinol!

    No full text
    International audienceBackground: While phloroglucinol is widely prescribed in European countries for its antispasmodic properties, recent high quality data failed to demonstrate its superiority to placebo in alleviating abdominal pain. Rumors suggest that injectable presentation of phloroglucinol may erase povidone-iodine stains. We thus aimed to evaluate its efficacy in this new indication.Methods: In this double-blind, controlled trial, we randomly assigned 9 squares of fabric obtained from common white coat to receive injectable phloroglucinol (experimental arm), stain remover (active control arm) or water (placebo arm). The primary efficacy endpoint was the change in stain intensity 10 min after the intervention.Results: In placebo and active control arms, povidone-iodine stains remained unchanged 10 min after treatment application. In contrast, the stain disappeared completely in the experimental arm.Conclusion: Injectable phloroglucinol was more effective than usual stain remover and water to remove povidone-iodine stains from white coats

    Vaginal Evisceration: An Unexpected Complication of Conization

    No full text
    Background. Large loop excision of the transformation zone (LLETZ) is routinely performed for the management of high grade intracervical neoplasia (CIN). Several uncommon complications have been described, including postoperative peritonitis, pseudoaneurysm of uterine artery, and bowel fistula. We report a unique case of postoperative vaginal evisceration and the subsequent management. Case. A 73-years-old woman underwent LLETZ for high grade CIN. On postoperative day 3, she was admitted for small bowel evisceration through the vagina. Surgical management was based on combined laparoscopic and transvaginal approach and consisted in bowel inspection and reinstatement, peritoneal washing, and dehiscence repair. Conclusions. Vaginal evisceration is a rare but potentially serious complication of pelvic surgery. This case report is to make clinicians aware of such complication following LLETZ and its management

    Early life microbial exposures shape the Crassostrea gigas immune system for lifelong and intergenerational disease protection

    No full text
    Background: The interaction of organisms with their surrounding microbial communities influences many biological processes, a notable example of which is the shaping of the immune system in early life. In the Pacific oyster, Crassostrea gigas , the role of the environmental microbial community on immune system maturation – and, importantly, protection from infectious disease – is still an open question. Results: Here, we demonstrate that early life microbial exposure durably improves oyster survival when challenged with the pathogen causing Pacific Oyster Mortality Syndrome (POMS), both in the exposed generation and in the subsequent one. Combining microbiota, transcriptomic, genetic, and epigenetic analyses, we show that the microbial exposure induced changes in epigenetic marks and a reprogramming of immune gene expression leading to long-term and intergenerational immune protection against POMS. Conclusions: We anticipate that this protection likely extends to additional pathogens and may prove to be an important new strategy for safeguarding oyster aquaculture efforts from infectious disease

    Early life microbial exposures shape the Crassostrea gigas immune system for lifelong and intergenerational disease protection

    No full text
    Background The interaction of organisms with their surrounding microbial communities influences many biological processes, a notable example of which is the shaping of the immune system in early life. In the Pacific oyster, Crassostrea gigas, the role of the environmental microbial community on immune system maturation – and, importantly, protection from infectious disease – is still an open question. Results Here, we demonstrate that early life microbial exposure durably improves oyster survival when challenged with the pathogen causing Pacific Oyster Mortality Syndrome (POMS), both in the exposed generation and in the subsequent one. Combining microbiota, transcriptomic, genetic, and epigenetic analyses, we show that the microbial exposure induced changes in epigenetic marks and a reprogramming of immune gene expression leading to long-term and intergenerational immune protection against POMS. Conclusions We anticipate that this protection likely extends to additional pathogens and may prove to be an important new strategy for safeguarding oyster aquaculture efforts from infectious disease

    Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study

    No full text
    International audienceObjectives: Because NRTIs can have fetal toxicities, we evaluated a perinatal NRTI-sparing strategy to prevent perinatal HIV transmission. Our primary objective was to determine the proportion maintaining a viral load (VL) of 50 copies/mL. Neonates received nevirapine prophylaxis for 14 days.Results: Of 89 patients switching to darunavir/ritonavir monotherapy, 4 miscarried before 22 weeks' gestation, 2 changed treatment for elevated liver enzymes without virological failure, and 83 were evaluable for the main outcome. Six had virological failure confirmed on a repeat sample (median VL=193 copies/mL; range 78-644), including two before switching to monotherapy. In these six cases, ART was intensified with tenofovir disoproxil fumarate/emtricitabine. The success rate was 75/83, 90.4% (95% CI, 81.9%-95.7%) considering two patients with VL missing at delivery as failures, and 77/83, 92.8% (95% CI, 84.9%-97.3%) when considering them as successes since both had undetectable VL on darunavir/ritonavir throughout pregnancy. In ITT, the last available VL before delivery was <50 copies/mL in all of the patients. There was no case of perinatal HIV transmission.Conclusions: Darunavir/ritonavir maintenance monotherapy required intensification in nearly 10% of cases. This limits its widespread use, thus other regimens should be evaluated in order to limit exposure to antiretrovirals, particularly NRTIs, during pregnancy
    corecore